author-photo

María Contel

City University of New York
Spanish National Research Council

77

Papers

2069

Citations

Citation Trend

Filter By

Papers (53) Sort By

Journal Conference Others

Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer.

2021 Chemistry: A European Journal
- María Contel
- Nazia Nayeem
Show All
- Source
- Cite
- Save
Citations (5)
Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.

2021 ChemMedChem
Show All
- Source
- Cite
- Save
Citations (1)
Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model.

2021 Inorganic Chemistry
Show All
- Source
- Cite
- Save
Citations (0)
SEC hyphenated to a multielement-specific detector unravels the degradation pathway of a bimetallic anticancer complex in human plasma

2020 Journal of Chromatography B
Show All
- Source
- Cite
- Save
Citations (2)
Unconventional Anticancer Metallodrugs and Strategies to Improve Their Pharmacological Profile

2019
- María Contel
Show All
- Source
- Cite
- Save
Citations (2)
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer

2019 European Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (23)
CHAPTER 6:Heterometallic Complexes as Anticancer Agents

2019
- Natalia Curado
- María Contel
Show All
- Source
- Cite
- Save
Citations (3)
Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

2019 Chemical Communications
Show All
- Source
- Cite
- Save
Citations (10)
Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide Design

2019 ACS Nano
Show All
- Source
- Cite
- Save
Citations (26)
Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma

2019 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (5)